Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    G1 Therapeutics Inc.

    NASDAQ: GTHX · Real-Time Price · USD
    7.16
    0.01 (0.14%)
    At close: Sep 17, 2024, 9:56 PM

    G1 Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 82.51M 51.3M 31.48M
    Cost of Revenue
    		 7.2M 3.75M 2.02M
    Gross Profit
    		 75.32M 47.55M 29.46M
    Operating Income
    		 -39.53M -136.18M -142.46M
    Interest Income
    		 2.47M 748K 43K
    Pretax Income
    		 -44.85M -145.86M -147.43M
    Net Income
    		 -47.97M -147.56M -148.35M
    Selling & General & Admin
    		 71.13M 100.42M 95.69M
    Research & Development
    		 43.71M 83.32M 76.22M
    Other Expenses
    		 n/a 3K -346K
    Operating Expenses
    		 114.84M 183.73M 171.92M
    Interest Expense
    		 10.04M 10.43M 4.67M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 122.04M 187.48M 173.93M
    Income Tax Expense
    		 3.12M 1.7M 925K
    Shares Outstanding (Basic)
    		 51.73M 43.63M 41.94M
    Shares Outstanding (Diluted)
    		 51.73M 43.63M 41.94M
    EPS (Basic)
    		 -0.93 -3.38 -3.54
    EPS (Diluted)
    		 -0.93 -3.38 -3.54
    EBITDA
    		 -39.01M -134.9M -142.46M
    EBIT
    		 -34.81M -135.43M -142.76M
    Depreciation & Amortization
    		 513K 530K 469K

    Add to Watchlist